BioCentury | Dec 28, 2019
Financial News

Elpiscience’s $100M series B provides path to IPO

...IPO, Ming Fang, head of global BD, told BioCentury. New investors Tencent, GTJA Investment Group, Dyee Capital...
BioCentury | Oct 17, 2019
Financial News

Oct. 16 Financial Quick Takes: Hong Kong IPO could value Ascentage at $876M; plus Principia, Rhythm, ProQR, dMed, Ionova and Amarna

...in a series A round led by Lilly Asia Ventures, with participation from angel investor Dyee Capital...
Items per page:
1 - 2 of 2
BioCentury | Dec 28, 2019
Financial News

Elpiscience’s $100M series B provides path to IPO

...IPO, Ming Fang, head of global BD, told BioCentury. New investors Tencent, GTJA Investment Group, Dyee Capital...
BioCentury | Oct 17, 2019
Financial News

Oct. 16 Financial Quick Takes: Hong Kong IPO could value Ascentage at $876M; plus Principia, Rhythm, ProQR, dMed, Ionova and Amarna

...in a series A round led by Lilly Asia Ventures, with participation from angel investor Dyee Capital...
Items per page:
1 - 2 of 2